AAAAAA
Results:
1-13
|
Results: 13
Authors:
Dujovne, CA
Tonkin, AM
Citation: Ca. Dujovne et Am. Tonkin, Ethical, medical and legal issues for the use of placebos in future lipid intervention trials, CURR OP LIP, 12(6), 2001, pp. 599-600
Authors:
Isaacsohn, J
Insull, W
Stein, E
Kwiterovich, P
Ma, P
Brazg, R
Dujovne, CA
Shan, M
Shugrue-Crowley, E
Ripa, S
Tota, R
Citation: J. Isaacsohn et al., Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia, CLIN CARD, 24(9), 2001, pp. 1-9
Authors:
Bays, HE
Moore, PB
Drehobl, MA
Rosenblatt, S
Toth, PD
Dujovne, CA
Knopp, RH
Lipka, LJ
LeBeaut, AP
Yang, B
Mellars, LE
CuffieJackson, C
Veltri, EP
Citation: He. Bays et al., Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: Pooled analysis of two phase II studies (vol 23, pg 1209, 2001), CLIN THER, 23(9), 2001, pp. 1601-1601
Authors:
Bays, HE
Moore, PB
Drehobl, MA
Rosenblatt, S
Toth, PD
Dujovne, CA
Knopp, RH
Lipka, LJ
LeBeaut, AP
Yang, B
Mellars, LE
Cuffie-Jackson, C
Veltri, EP
Citation: He. Bays et al., Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: Pooled analysis of two phase II studies, CLIN THER, 23(8), 2001, pp. 1209-1230
Authors:
Dujovne, CA
Bays, H
Davidson, MH
Knopp, R
Hunninghake, DB
Stein, EA
Goldberg, AC
Jones, P
Lipka, LJ
Cuffie-Jackson, C
Citation: Ca. Dujovne et al., Reduction of LDL cholesterol in patients with primary hypercholesterolemiaby SCH 48461: Results of a multicenter dose-ranging study, J CLIN PHAR, 41(1), 2001, pp. 70-78
Authors:
Insull, W
Koren, M
Davignon, J
Sprecher, D
Schrott, H
Keilson, LM
Brown, AS
Dujovne, CA
Davidson, MH
McLain, R
Heinonen, T
Citation: W. Insull et al., Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia, ATHEROSCLER, 157(1), 2001, pp. 137-144
Authors:
Dujovne, CA
Zavoral, JH
Rowe, E
Mendel, CM
Citation: Ca. Dujovne et al., Effects of sibutramine on body weight and serum lipids: A double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia, AM HEART J, 142(3), 2001, pp. 489-497
Authors:
Davidson, MH
Stein, EA
Hunninghake, DB
Ose, L
Dujovne, CA
Insull, W
Bertolami, M
Weiss, SR
Kastelein, JJP
Scott, RS
Campodonico, S
Escobar, ID
Schrott, HG
Bays, H
Stepanavage, ME
Wu, M
Tate, AC
Melino, MR
Kush, D
Mercuri, M
Mitchel, YB
Citation: Mh. Davidson et al., Lipid-altering efficacy and safety of simvastatin 80 mg/day: Worldwide long-term experience in patients with hypercholesterolemia, NUTR MET CA, 10(5), 2000, pp. 253-262
Authors:
Dujovne, CA
Knopp, R
Kwiterovich, P
Hunninghake, D
McBride, TA
Poland, M
Citation: Ca. Dujovne et al., Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1030 hypercholesterolemic patients, MAYO CLIN P, 75(11), 2000, pp. 1124-1132
Authors:
Kastelein, JJP
Isaacsohn, JL
Ose, L
Hunninghake, DB
Frohlich, J
Davidson, MH
Habib, R
Dujovne, CA
Crouse, JR
Liu, MZ
Melino, MR
O'Grady, L
Mercuri, M
Mitchel, YB
Citation: Jjp. Kastelein et al., Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels, AM J CARD, 86(2), 2000, pp. 221-223
Authors:
Dujovne, CA
Harris, WS
Altman, R
Overhiser, RW
Black, DM
Citation: Ca. Dujovne et al., Effect of Atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients, AM J CARD, 85(3), 2000, pp. 350-353
Authors:
Knopp, RH
Superko, HR
Davidson, M
Insull, W
Dujovne, CA
Kwiterovich, PO
Zavoral, JH
Graham, K
O'Connor, RR
Edelman, DA
Citation: Rh. Knopp et al., Long-term blood cholesterol-lowering effects of a dietary fiber supplement, AM J PREV M, 17(1), 1999, pp. 18-23
Authors:
Guyton, JR
Dujovne, CA
Illingworth, DR
Citation: Jr. Guyton et al., Dual hepatic metabolism of cerivastatin-clarifications, AM J CARD, 84(4), 1999, pp. 497-497
Risultati:
1-13
|